ACE2 and breast carcinoma: Since it could disrupt the production of vascular endothelial growth factor (VEGF), interfering with angiogenesis and tumor growth, ACE-2 upregulation hindered migration and invasion of breast cancer cells both in vivo and in vitro [47].